Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy-Reference-Cited by-同舟云学术

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy

Published:2019-02-20 Issue:2 Volume:14 Page:e0211105
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kim Sung Han,Kim Jung Kwon,Park Eun Young^ORCID,Joo Jungnam,Lee Kang Hyun,Seo Ho Kyung,Joung Jae Young,Chung Jinsoo^ORCID

Funder

Research and institute of National Cancer Center

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview;RJ Motzer;Oncologist,2011

2. Renal cell carcinoma;E Jonasch;BMJ,2014

3. Kidney cancer, version 3.2015;RJ Motzer;J Natl Compr Canc Netw,2015

4. Defining an individualized treatment strategy for metastatic renal cancer;B Hu;Urol Clin North Am,2012

5. New insights into the management of renal cell cancer;N Pecuchet;Oncology,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of immunotherapy on liver metastasis;World Journal of Gastrointestinal Surgery;2024-07-27

2. Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review;Medicine;2024-05-24

3. Combination of radiotherapy and Anlotinib enhances benefit from immunotherapy to liver metastasis and abscopal tumor from lung cancer;International Immunopharmacology;2024-02

4. A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning;Frontiers in Endocrinology;2023-01-05

5. Oligometastatic Disease in the Liver: The Role of Interventional Oncology;The British Journal of Radiology;2022-10-01